News summary

Engineering a multilayer microfluidic airway-on-a-chip with tunable GelMA hydrogel for physiologically relevant aerosol exposure studies

Source: Nature - Biotechnology • Published: 09 Sept 2026, 00:00

Summarized by Masters of Longevity from Nature - Biotechnology.

Describes a multilayer microfluidic airway-on-a-chip using tunable GelMA hydrogel to model small airways and enable controlled aerosol exposure studies.

Engineering a multilayer microfluidic airway-on-a-chip with tunable GelMA hydrogel for physiologically relevant aerosol exposure studies
Key Takeaways
  • The device integrates a GelMA hydrogel stromal layer with compartmentalized microchannels and a perfusable lumen to mimic airway architecture.
  • The GelMA formulation was optimized to support fibroblast encapsulation, endothelial adhesion, and mechanical stability.
  • Coupling the chip with a custom aerosol system produced inflammatory and fibrotic responses after TGF-β1 and whole wood smoke exposure.
Read the full article at Nature - Biotechnology

Continue exploring

Recommended MoL Picks

MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickCan You Really Measure Whether You’re Aging More Slowly?A younger epigenetic-age score can look like proof that an intervention is working. A major new analysis shows which clocks detect change—and why movement is not yet the same as longer healthspan.